This story is part of When the Drugs Hit, a Motherboard journey into the science, politics, and culture of today's psychedelic renaissance. Follow along here.
In 1988, Rick Strassman set out to do what seemed to be impossible: convince the US government to let him give people illegal drugs.
But not just any illegal substances. Strassman, a psychiatrist at the University of New Mexico, wanted to dose subjects with one of the most potent psychedelics ever discovered: dimethyltryptamine (DMT), a neurotransmitter and tryptamine molecule that naturally occurs in the plant and animal kingdoms, including in humans. Strassman hoped to investigate the physiological and psychological effects of DMT, the so-called "spirit molecule," but knew that getting approval to do this research was a long shot.
Like pretty much every other psychedelic drug known at the time, DMT had been classified as a Schedule I substance under the 1970 Comprehensive Drug Abuse Prevention and Control Act. This meant that there was no recognized medical use for the substances and effectively placed a moratorium on all psychedelic research using human subjects. Studying and administering substances gets progressively easier as you move from Schedule I to Schedule V. Substances in Schedule I, including heroin, are the only ones, in fact, that require a special license to study.
But these obstacles didn't deter Strassman. After 19 months of arduous paperwork and a seemingly interminable argument with the Drug Enforcement Administration, in early 1990 he dosed his first participant with DMT. It was the first psychedelic study using humans in two decades.
"I figured as long as the DEA weren't saying no, it remained a potential yes," Strassman told me recently. "I never really gave up."
"'I don't care if you guys are smoking mushrooms back there, just keep out of the paper, get your grants and keep your cards close to your chest.'"
In the nearly three decades since Strassman's groundbreaking DMT study, little has changed for researchers hoping to study the effects of psychedelic compounds on humans. Although psychedelic research is experiencing a sort of renaissance, getting approval to study these substances is more difficult than ever.
At the same time, recent work done on psychedelics has shown potential in treating everything from post-traumatic stress in veterans to promoting creative problem solving and treating addictions.
If the federal decision to classify these substances as having no medical value was premature, then understanding the benefits (and dangers) of psychedelics in a rigorous and empirical way has been hindered by bureaucracy and authorities policing research laboratories. I reached out to Strassman and contemporary clinicians to learn more about their experiences and the difficulties faced by psychedelic researchers today. Just how hard was itis itto get the greenlight from Uncle Sam?
That's getting ahead. For most psychedelic scientists, problems begin at the local level.
*
To do science on humans with illegal substances, researches are required to submit a proposal to an institutional review board, which is supposed to ensure the experiment is both ethical and safe. Given the taboo surrounding psychedelics and universities' tendency to avoid controversy, even the safest and most well-designed studies may flounder on the shores of a dean's idea of what constitutes respectable science.
Fortunately for Strassman, he said the University of New Mexico was somewhat "off the beaten path," and that his psychedelic study was much less likely to draw significant attention than if it had been conducted at an Ivy League institution. Moreover, Strassman said neither his department chair nor the university president really cared what he was up to in his lab, so long as he "kept his nose clean."
Read More: America's Trippiest Chemist Says Making Psychedelics 'Was Fun'
"I spoke with the chairman of the research unit and he said, 'I don't care if you guys are smoking mushrooms back there, just keep out of the paper, get your grants and keep your cards close to your chest,'" Strassman remembered.
After gaining approval from the university, Strassman then had to make his pitch at the federal level, specifically the DEA and the Food and Drug Administration. The DEA was responsible for doling out Schedule I licenses, which authorized licensees to possess these illicit substances. The FDA, for its part, would give Strassman approval for what's known as an IND, or Investigative New Drug trial, which would allow him to administer the Schedule I substance to human subjects.
There was only one problem: The DEA wanted to see the FDA's IND license before granting its Schedule I license, and the FDA, in turn, wanted to see that Strassman was approved to use the Schedule I substance before granting the IND. It was a catch-22.
But as Strassman began to facilitate unprecedented degrees of contact between these two federal agencies, he realized he had a far more pressing problem to deal with: how to procure the DMT for the trials in the first place. In order to get his Schedule I license from the DEA, he would have to show that the DMT was pure, and that he would only have access to a limited and necessary amount of the substance.
Eventually Strassman linked up with Dave Nichols, a chemist at Purdue University with DEA approval to synthesize 15 Schedule I psychedelics and 20 years of experience doing just that. After finding a hookup for the DMT, Strassman returned to the DEA and started filling out the paperwork.
Several months later, Strassman had his Schedule I license and IND. It had been over a year-and-a-half of starts, stops, and red tape. But he was finally set to begin his research.
DMT crystals. Photo: Psychonaught/Wikimedia Commons
When Strassman was setting out, he had to rely on trial and error in his dealings with the feds, who were less than receptive to the idea of allowing Schedule I substances to be opened for research purposes.
The first paper Strassman wrote after receiving approval for his study was about how he managed to even make this happena kind of blueprint for getting approval to do psychedelic science. Although he was criticized for revealing hard-won, "sensitive" information about government legal processes, his blueprint was effective. According to Strassman, it helped guide researchers at the University of Arizona, University of Miami, and Johns Hopkins University set up their own studies on psilocybin (the psychedelic compound in "magic mushrooms") and ibogaine in the late 90s and early 2000s.
But overregulation continues to crush psychedelic science. Even with Strassman's blueprint and a number of precedents in place, getting approval to study psychedelics is still a steep challenge.
The Multidisciplinary Association for Psychedelic Studies (MAPS), for example, has been pushing the limits of psychedelic research for decades now, yet its trials on MDMA and PTSD keep stalling out in a maze of bureaucratic and legal obstacles.
MAPS hopes to begin the third and final FDA study this year, and to see MDMA be a FDA-approved prescription medicine by 2021. But the phase 3 study is also the most difficult since it requires special parameters for the trials, which include large cohorts of study participants as well as using chemicals produced under a Good Manufacturing Practices (GMP) regime. GMPs are mostly quality control measures, but since the MDMA used in the first two phases was already 99 percent pure, this means that GMP is mostly a regulatory requirement that places copious paperwork and protocols on the researchers for the duration of the trial phase.
"Rescheduling would release a lot of these barriers that exist only for Schedule I substances."
This also means that MAPS will have to find a new source for its MDMA since the drug must be manufactured under GMP conditions. Even though pharma companies like Sigma-Aldrich have websites set up where you can order small quantities of every imaginable psychedelic, these won't meet the phase 3 GMP requirements. Natalie Ginsberg, a MAPS policy and advocacy manager, said so far just finding a manufacturer for the stuff has been hard enough.
Then there's the money problem. Historically, most psychedelic studies have been funded by the National Institute of Drug Addiction (NIDA). Although NIDA's pockets run deep, the agency is particular about the kind of drug research it will fundthat is to say, only research that investigates the abuse potential of substances, not their therapeutic potential. As such, organizations like MAPS have had to seek private funding for studies, which, all told, will cost millions of dollars. The GMP MDMA alone will cost nearly $500,000 for 1.5 kilos.
In this respect, Strassman realizes he was lucky. For his DMT trials, he had secured two competitive grants to support him during the year-and-a-half it took to get approval just to begin his research. Without this grant money, Strassman said it's unlikely he would've had the time or energy to pursue this research project.
Ultimately, he and Ginsberg see the difficulties faced by researchers as a consequence of the War on Drugs and its scheduling regime.
"All these extra burdens put on researchers like waiting for a Schedule I license, finding the right location, finding a manufacturer of the drug, add months or years to the process," said Ginsberg. "People who do psychedelic research aren't just any old researchersthey have to be committed and willing to fight through the regulations and have patience to wait for months on end for approval. Rescheduling would release a lot of these barriers that exist only for Schedule I substances."
Read More: How to Legally Buy a Kilo of Pure MDMA
Strassman likewise said he'd like to see psychedelic substances rescheduled, though he realizes researchers are caught between a rock and a hard place. To keep psychedelics as Schedule I substances makes researching them prohibitively hard, but to call for reclassifying them as Schedule II substances is unlikely to succeed either.
Schedule II substances, including stimulants like cocaine and Adderall, can be prescribed by everyone from dentists to veterinarians. As Strassman sees it, trying to argue that something like LSD should be as easily accessible as Adderall is a non-starter. Instead, he advocates for a new, intermediate schedule between I and II, that would make the substances easier to study, but not absurdly easy for a layperson to obtain.
"I think that category of clinical reality ought to be combined with a legal category of the scheduling," Strassman said. "People wouldn't be able to possess and give these drugs without special training and without certification and supervision, but if you keep them kind of behind the lock and key of Schedule I, you're also not going to be able to give them to people who might benefit."
Link:
Stop Policing Psychedelic Science - Motherboard
- 8 Mystical Herbs and Legal Psychedelics For Lucid Dreaming [Last Updated On: December 8th, 2016] [Originally Added On: December 8th, 2016]
- Psychedelics: LSD, Mushrooms, Salvia | Facts | Drug Policy ... [Last Updated On: December 10th, 2016] [Originally Added On: December 10th, 2016]
- FS Book Company - Marijuana Books [Last Updated On: December 12th, 2016] [Originally Added On: December 12th, 2016]
- Psychedelic - PsychonautWiki [Last Updated On: December 27th, 2016] [Originally Added On: December 27th, 2016]
- From Alzheimer's To Psychedelics, 2016 Was A Good Year For ... [Last Updated On: January 3rd, 2017] [Originally Added On: January 3rd, 2017]
- LSD - Psychedelic Effects - The Good Drugs Guide [Last Updated On: January 5th, 2017] [Originally Added On: January 5th, 2017]
- THC - Psychedelics [Last Updated On: January 29th, 2017] [Originally Added On: January 29th, 2017]
- Psychedelics | Pharmacological Reviews [Last Updated On: January 30th, 2017] [Originally Added On: January 30th, 2017]
- Dorian Yates reveals all on steroids, body dysmorphia, psychedelics, cannabis and yoga - Express.co.uk [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Psychedelic drug therapy including magic mushrooms, LSD and ... - CBS News [Last Updated On: February 7th, 2017] [Originally Added On: February 7th, 2017]
- Psychedelics Being Tested For Use In Treating Various Conditions - CBS Local [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- The psychedelic renaissance - Boulder Weekly [Last Updated On: February 9th, 2017] [Originally Added On: February 9th, 2017]
- Buy psychedelics online : Chinglabs.com [Last Updated On: February 12th, 2017] [Originally Added On: February 12th, 2017]
- Psychedelic drugs like magic mushrooms and LSD have key ... - Yahoo Finance [Last Updated On: February 13th, 2017] [Originally Added On: February 13th, 2017]
- Psychedelics a Viable Therapeutic Option for Depression - Psychiatry Advisor [Last Updated On: February 14th, 2017] [Originally Added On: February 14th, 2017]
- Is Silicon Valley Onto Something With Its LSD Microdosing? - Newsweek [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- News Releases - Noozhawk [Last Updated On: February 16th, 2017] [Originally Added On: February 16th, 2017]
- A Revolution in the Science of Psychedelics is Happening in Boulder - 303 Magazine [Last Updated On: February 16th, 2017] [Originally Added On: February 16th, 2017]
- When Reality Is More Intense Than Psychedelics: Strand Of Oaks ... - NPR [Last Updated On: February 17th, 2017] [Originally Added On: February 17th, 2017]
- Psychedelics Help Reduce Opioid Addiction, According to New Study - AlterNet [Last Updated On: February 22nd, 2017] [Originally Added On: February 22nd, 2017]
- Psychedelics May Help Reduce Opioid Addiction, According To ... - Huffington Post [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Psychedelics Help Reduce Opioid Addiction, According to New Study - eNews Park Forest [Last Updated On: February 24th, 2017] [Originally Added On: February 24th, 2017]
- Psychedelics Could Play A Role In Tackling The Opioid Epidemic - Huffington Post [Last Updated On: February 24th, 2017] [Originally Added On: February 24th, 2017]
- Meet The People's Champion of Psychedelic Drugs - Narratively [Last Updated On: February 27th, 2017] [Originally Added On: February 27th, 2017]
- How psychedelics like psilocybin and LSD actually change the way ... - Yahoo Finance [Last Updated On: February 27th, 2017] [Originally Added On: February 27th, 2017]
- First U. student group on studying psychedelics holds open house - The Daily Princetonian [Last Updated On: February 27th, 2017] [Originally Added On: February 27th, 2017]
- How psychedelics like psilocybin and LSD actually change the way people see the world - Businessinsider India [Last Updated On: February 28th, 2017] [Originally Added On: February 28th, 2017]
- Psychedelics Help Reduce Opioid Addiction, According to New ... [Last Updated On: February 28th, 2017] [Originally Added On: February 28th, 2017]
- WATCH: A Public Policy Expert Explains How to Safely Deregulate LSD and Other Psychedelics - AlterNet [Last Updated On: March 7th, 2017] [Originally Added On: March 7th, 2017]
- Quotes About Psychedelics (48 quotes) [Last Updated On: March 7th, 2017] [Originally Added On: March 7th, 2017]
- Inside the Psychedelic Underground - RollingStone.com [Last Updated On: March 9th, 2017] [Originally Added On: March 9th, 2017]
- What Psychedelics Really Do to Your Brain - Rolling Stone - RollingStone.com [Last Updated On: March 10th, 2017] [Originally Added On: March 10th, 2017]
- Hallucinogens Help, According to a Mom's Memoir and Son's Documentary - Bedford + Bowery [Last Updated On: April 8th, 2017] [Originally Added On: April 8th, 2017]
- Meditation and the psychedelic drug ayahuasca seem to change the brain in surprisingly similar ways - Businessinsider India [Last Updated On: April 8th, 2017] [Originally Added On: April 8th, 2017]
- Tripping out: the highs and lows of psychedelic therapy - Marie Claire UK [Last Updated On: April 8th, 2017] [Originally Added On: April 8th, 2017]
- America's Trippiest Chemist: Making Psychedelics 'Was Fun' - Motherboard [Last Updated On: June 6th, 2017] [Originally Added On: June 6th, 2017]
- The Three Types of Hallucinogens: Psychedelics ... [Last Updated On: June 7th, 2017] [Originally Added On: June 7th, 2017]
- Cary Grant was one of the first to benefit from LSD therapy - Quartz [Last Updated On: June 11th, 2017] [Originally Added On: June 11th, 2017]
- What it's like to take psychedelics in small doses at breakfast - New Scientist [Last Updated On: June 14th, 2017] [Originally Added On: June 14th, 2017]
- 'Changing Our Minds' explores psychedelic drugs and spiritual healing - Religion News Service [Last Updated On: June 14th, 2017] [Originally Added On: June 14th, 2017]
- Q&A With Psychedelic Stand-Up and LaughFest Headliner Shane Mauss - Flagpole Magazine [Last Updated On: June 20th, 2017] [Originally Added On: June 20th, 2017]
- Q&A: LaughFest comedian talks science and psychedelics - Red and Black [Last Updated On: June 20th, 2017] [Originally Added On: June 20th, 2017]
- 'Changing Our Minds' explores psychedelic drugs and spiritual healing - The Daily Tribune [Last Updated On: June 21st, 2017] [Originally Added On: June 21st, 2017]
- Shane Mauss brings Good Trip Comedy Tour to town - Chattanooga Times Free Press [Last Updated On: June 22nd, 2017] [Originally Added On: June 22nd, 2017]
- 'Changing Our Minds' explores psychedelic drugs and spiritual healing - The Oakland Press [Last Updated On: June 22nd, 2017] [Originally Added On: June 22nd, 2017]
- Director Ana Lily Amirpour on Cannibalism, Psychedelics, and 'Horrifying' Racism Allegations - Jezebel [Last Updated On: June 23rd, 2017] [Originally Added On: June 23rd, 2017]
- Majority of Americans ready to embrace psychedelic therapy - YouGov US [Last Updated On: June 24th, 2017] [Originally Added On: June 24th, 2017]
- The Refugee Funding America's Psychedelic Renaissance - VICE [Last Updated On: June 24th, 2017] [Originally Added On: June 24th, 2017]
- Open Your Mind This Weekend at Europe's Largest Psychedelic Conference - VolteFace Magazine (blog) [Last Updated On: June 27th, 2017] [Originally Added On: June 27th, 2017]
- Psychedelics and Virtual Reality Make a Trendy but Illegal Therapy - Inverse [Last Updated On: June 27th, 2017] [Originally Added On: June 27th, 2017]
- The war on drugs is back. Will psychedelic drug research survive? - The Verge [Last Updated On: June 29th, 2017] [Originally Added On: June 29th, 2017]
- Tune in, Turn on, Stay in School - Study Breaks [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Cannabist Show: He's psychedelic comedian Shane Mauss - The Cannabist [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- The brain on DMT: mapping the psychedelic drug's effects - Wired.co.uk [Last Updated On: July 3rd, 2017] [Originally Added On: July 3rd, 2017]
- Psychedelics Could Help Asia's Mental Health Care, But Stigma Remains Roadblock - TheFix.com [Last Updated On: July 3rd, 2017] [Originally Added On: July 3rd, 2017]
- Is LSD the new coffee? - FactorDaily [Last Updated On: July 4th, 2017] [Originally Added On: July 4th, 2017]
- My grandfather was a death row doctor. He tested psychedelic drugs on Texas inmates. - Texas Tribune [Last Updated On: July 5th, 2017] [Originally Added On: July 5th, 2017]
- About Us | Trusted News Source for Psychedelic Research ... [Last Updated On: July 6th, 2017] [Originally Added On: July 6th, 2017]
- Do Psychedelic Drugs Cause the 'Prophetic Effect'? - Breaking Israel News [Last Updated On: July 11th, 2017] [Originally Added On: July 11th, 2017]
- Are psychedelics the new medical marijuana? - WTSP 10 News [Last Updated On: July 14th, 2017] [Originally Added On: July 14th, 2017]
- Psychiatrists Say Cannabis Medicine Has Psychedelic Properties - The Marijuana Times [Last Updated On: July 15th, 2017] [Originally Added On: July 15th, 2017]
- Can Psychedelics Be Therapy? Allow Research to Find Out - New York Times [Last Updated On: July 17th, 2017] [Originally Added On: July 17th, 2017]
- Countdown To (Legalized) Ecstasy! Rick Doblin, MAPS, & the Psychedelic Renaissance [Podcast] - Reason (blog) [Last Updated On: July 20th, 2017] [Originally Added On: July 20th, 2017]
- Should We Reclassify Marijuana as a Hallucinogen? - Big Think [Last Updated On: July 20th, 2017] [Originally Added On: July 20th, 2017]
- Do You Take Drugs at Festivals? This Initiative is Working on Keeping You Safe - PoliticalCritique.org [Last Updated On: July 20th, 2017] [Originally Added On: July 20th, 2017]
- Psychedelic drugs could tackle depression in a way that antidepressants can't - INSIDER [Last Updated On: July 22nd, 2017] [Originally Added On: July 22nd, 2017]
- Psychedelic Shine takes a trip to the skies in Boulder - Boulder Daily Camera [Last Updated On: July 22nd, 2017] [Originally Added On: July 22nd, 2017]
- Reasons to Consider Trying Psychedelics - FoxWeekly [Last Updated On: July 27th, 2017] [Originally Added On: July 27th, 2017]
- Psychedelics and Normality - HuffPost [Last Updated On: July 27th, 2017] [Originally Added On: July 27th, 2017]
- New book about psychedelics and weird human experiences - Boing Boing [Last Updated On: July 27th, 2017] [Originally Added On: July 27th, 2017]
- Scientists Want You to Give Them Money to Study ... [Last Updated On: July 29th, 2017] [Originally Added On: July 29th, 2017]
- What Has Awe Done for Me Lately? - HuffPost [Last Updated On: August 1st, 2017] [Originally Added On: August 1st, 2017]
- For children, it's beyond psychedelics - The Hans India - The Hans India [Last Updated On: August 1st, 2017] [Originally Added On: August 1st, 2017]
- Expanding consciousness - 48 Hills [Last Updated On: August 2nd, 2017] [Originally Added On: August 2nd, 2017]
- THE FUTURE OF PSYCHEDELICS: Are LSD and Mushrooms The New Prozac? - Dope Magazine [Last Updated On: August 5th, 2017] [Originally Added On: August 5th, 2017]
- Psychedelic drugs saved my life. So why aren't they prescribed? - Wired.co.uk [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- LSD as therapy: How scientists are reclaiming psychedelics ... [Last Updated On: August 9th, 2017] [Originally Added On: August 9th, 2017]
- The foundation of Western philosophy is probably rooted in psychedelics - Quartz [Last Updated On: August 12th, 2017] [Originally Added On: August 12th, 2017]
- Crazy Enough to be Correct - HuffPost [Last Updated On: August 15th, 2017] [Originally Added On: August 15th, 2017]
- How MDMA & Other Psychedelics Could Change Therapy | Goop [Last Updated On: August 20th, 2017] [Originally Added On: August 20th, 2017]